Myelin Formation and Motor Learning in Adulthood
What is the function of continued adult myelination in the normal undiseased brain? A recent study sheds remarkable light on this process and its importance.
A Big Step Forward for Spinal Muscular Atrophy?
Potential approaches to devising strategies that may allow amelioration of this disease are revealed in a recent study. But questions remain.
Epilepsy Therapy Update: A Whirlwind Review
Quick, how many of the following—eslicarbazepine, ezogabine, parampanel—do you recognize? These new entries into the medical armamentarium were highlighted at the AAN 2015 Annual Meeting.
Drug Switching in Active Relapsing Remitting MS
A switch to a second-line drug in a patient receiving first-line therapies likely will be effective at decreasing disease activity.
Adult Encephalitis: What Are We Really Talking About?
The ultimate cause is found in only about half of patients, so improved understanding of the prognostic and diagnostic features is of high priority.
Stratifying PML Risk in Multiple Sclerosis
The risk of progressive multifocal leukoencephalopathy in patients receiving Tysabri for MS is a concern about this otherwise extremely effective therapy.
Sudden Unexpected Death in Epilepsy: When to Discuss
The possibility of SUDEP should serve as a powerful motivator for improved adherence and active attempts at seizure control with new medications, neurostimulation, and epilepsy surgery.
The Sports Neurologist: A Welcome Addition to the Sideline
Previously, the football sideline was the sole domain of orthopedic surgeons and athletic trainers. Neurologists are now part of a growing team of physicians with an interest in treating athletes.
Tests for Autoantibodies in Brain Disease Raise Questions
Serum testing for NMDAR and other autoantibodies is fraught with pitfalls, and careful clinical consideration is important.
Neuromyelitis Optica, Multiple Sclerosis, and in Between
What emerged is that Devic’s is a distinct syndrome that results in widespread destructive lesions in the spinal cord that are not strictly demyelinating in their onset. Interesting questions remain.